NCT02153333 - Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™ | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Infections, Rotavirus

Interventions

PROCEDURE

Serum sample

Serum samples collected at pre-vaccination and at 1-2 months post Dose 2 in the previously conducted clinical trials will be assessed for anti-PCV-1 antibodies in this study. Additionally, pre-vaccination sera samples from any infants testing positive for PCV-1 antibodies at the post-vaccination time point will also be evaluated.